Recent studies have shown that FGF21 can also act as a predictor of atherosclerosis by inhibiting mitochondrial fragmentation to reduce ROS production, and ultimately reducing NLRP3-mediated cellular death in endothelial cells to resist atherosclerosis (50, 51). Here, NLRP3 is linked to atherosclerosis.